Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1666-2023Class I

StealthStation Cranial Software, Model: 9735585, used with StealthStation S7/i7 systems

Medtronic Navigation, Inc / initiated 2023-04-11 / Open, Classified / root cause: software

Medtronic Navigation, Inc. began a recall of StealthStation Cranial Software, Model: 9735585, used with StealthStation S7/i7 systems on . FDA classified it as Class I and gives the reason as "In nonaxial/some axial exams if surgical plan utilized, Target Guidance selected, tip projection utilized, Navigate Projection enabled, software anomaly may occur during tumor resection/shunt placement/deep brain...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as software.

Recall record

Recall number
Z-1666-2023
Classification
Class I
Status
Open, Classified
Initiated
Posted
Recalling firm
Medtronic Navigation, Inc
Product
StealthStation Cranial Software, Model: 9735585, used with StealthStation S7/i7 systems
Product code
HAW Neurological Stereotaxic Instrument
Reason for recall
In nonaxial/some axial exams if surgical plan utilized, Target Guidance selected, tip projection utilized, Navigate Projection enabled, software anomaly may occur during tumor resection/shunt placement/deep brain stimulation, where distance to/past target text no longer synchronized with navigation information, inaccurate value displayed; may result in prolonged/additional procedure, tissue injury
Root cause tag
software
FDA root cause
Software design
Action
On 4/11/23, "URGENT: MEDICAL DEVICE CORRECTION" notices were sent to healthcare professionals that were advised of the following; 1) Do not utilize the Distance to/past Target value for Tumor Resection, Shunt Placement, and DBS procedures. Per the IFU: "Warning: Frequently confirm navigation accuracy and system responsiveness during live navigation. Use the navigation instrument to touch several bony anatomical landmarks and confirm that the locations identified on the images match the locations touched on the patient. If accuracy degrades, re-register the patient." and "If system navigation seems inaccurate and steps to restore accuracy are unsuccessful, abort use of the system." 2) All physician users should review the correction notice. Pass on the notice to all those who need to be aware within your organization or to any organization where the potentially affected devices have been transferred. Please maintain a copy of this notice in your records. 3) Complete and return the customer confirmation form that can be returned to [email protected]. Firm will provide warning and instructional placards to be applied to the affected systems. Firm is currently working on a software update. If you have any questions related to this issue, contact Technical Services for help at: 1-888-826-5603 or email at [email protected]
Quantity in commerce
556
Distribution
US Distribution: PR. OUS (foreign) distribution: ARGENTINA, AUSTRALIA, AUSTRIA, BAHRAIN, BELGIUM, BOSNIA and HERZEGOVINA, BRAZIL, BULGARIA, CANADA, CANARY ISLANDS, CHILE, Colombia COLOMBIA, C¿TE D'IVOIRE, CROATIA, CZECH REPUBLIC, DENMARK, DOMINICAN REPUBLIC, ECUADOR, FINLAND, FRANCE, GERMANY, GREECE, GUADELOUPE, HUNGARY, INDIA, IRELAND, ISRAEL, ITALY, JAPAN, KENYA, LATVIA, MEXICO, MOLDAVIA, NETHERLANDS, PAKISTAN, POLAND, PORTUGAL, REPUBLIC of KOREA, ROMANIA, RUSSIAN FEDERATION, SAUDI ARABIA, SINGAPORE, SLOVENIA, SOUTH AFRICA, SPAIN, SRI LANKA, SWEDEN, SWITZERLAND, THAILAND, TURKEY, UNITED ARAB EMIRATES
Product codes and lots
Model/UDI-DI/Software Versions: 9735585/00763000253165, 00763000306762 (inside Kits: 00763000299927, 00763000299972), 00763000517267(inside Kits: 00763000517274, 00763000517335)/v3.1.1, 3.1.2, and 3.1.3

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1666-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1666-2023Class IOngoingVoluntary: Firm initiated